TENX - Tenax Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
8.23M
Enterprise Value 3
-663.58k
Trailing P/E
N/A
Forward P/E 1
-1.39
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
0.94
Enterprise Value/Revenue 3
N/A
Enterprise Value/EBITDA 6
0.09

Trading Information

Stock Price History

Beta (3Y Monthly) 1.84
52-Week Change 3-75.61%
S&P500 52-Week Change 38.78%
52 Week High 36.3900
52 Week Low 31.0300
50-Day Moving Average 31.2557
200-Day Moving Average 31.3801

Share Statistics

Avg Vol (3 month) 365.31k
Avg Vol (10 day) 324.88k
Shares Outstanding 56.74M
Float 6.35M
% Held by Insiders 14.73%
% Held by Institutions 114.31%
Shares Short (Sep 30, 2019) 4100.21k
Short Ratio (Sep 30, 2019) 42.46
Short % of Float (Sep 30, 2019) 41.67%
Short % of Shares Outstanding (Sep 30, 2019) 41.49%
Shares Short (prior month Aug 30, 2019) 4181.53k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 220/1
Last Split Date 3Feb 26, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-54.17%
Return on Equity (ttm)-96.03%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -7.23M
Net Income Avi to Common (ttm)-14.46M
Diluted EPS (ttm)-3.9450
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)8.91M
Total Cash Per Share (mrq)1.32
Total Debt (mrq)222.96k
Total Debt/Equity (mrq)2.59
Current Ratio (mrq)10.05
Book Value Per Share (mrq)1.29

Cash Flow Statement

Operating Cash Flow (ttm)-6.8M
Levered Free Cash Flow (ttm)-4.47M